Generix SA

ENXTPA:GENX Stock Report

Market Cap: €220.0m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Generix Past Earnings Performance

Past criteria checks 2/6

Key information

45.59%

Earnings growth rate

44.20%

EPS growth rate

Software Industry Growth15.21%
Revenue growth rate5.46%
Return on equity9.61%
Net Margin4.04%
Last Earnings Update31 Mar 2022

Recent past performance updates

Analysis Article Dec 22

Does Generix's (EPA:GENX) Statutory Profit Adequately Reflect Its Underlying Profit?

Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...

Recent updates

Analysis Article Apr 29

Returns On Capital Are Showing Encouraging Signs At Generix (EPA:GENX)

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Analysis Article Mar 30

A Look At The Fair Value Of Generix SA (EPA:GENX)

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Generix SA ( EPA:GENX...
Analysis Article May 04

Generix (EPA:GENX) Has More To Do To Multiply In Value Going Forward

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Analysis Article Mar 08

What Kind Of Investors Own Most Of Generix SA (EPA:GENX)?

Every investor in Generix SA ( EPA:GENX ) should be aware of the most powerful shareholder groups. Institutions will...
Analysis Article Feb 15

Is Generix's (EPA:GENX) 194% Share Price Increase Well Justified?

When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...
Analysis Article Jan 27

Does Generix (EPA:GENX) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Jan 09

Here's What To Make Of Generix's (EPA:GENX) Returns On Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article Dec 22

Does Generix's (EPA:GENX) Statutory Profit Adequately Reflect Its Underlying Profit?

Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...
Analysis Article Dec 07

Could The Market Be Wrong About Generix SA (EPA:GENX) Given Its Attractive Financial Prospects?

With its stock down 6.6% over the past three months, it is easy to disregard Generix (EPA:GENX). But if you pay close...
Analysis Article Nov 19

What Is Generix SA's (EPA:GENX) Share Price Doing?

Generix SA (EPA:GENX), is not the largest company out there, but it saw significant share price movement during recent...

Revenue & Expenses Breakdown

How Generix makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:GENX Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2285360
31 Mar 2180440
31 Dec 2080340
30 Sep 2079240
30 Jun 2080340
31 Mar 2081340
31 Dec 1980450
30 Sep 1979550
30 Jun 1978450
31 Mar 1977250
31 Dec 1875150
30 Sep 1873050
30 Jun 1872150
31 Mar 1870150
31 Dec 1769040
30 Sep 1768040
30 Jun 1765040
31 Mar 1763040
31 Dec 1662040
30 Sep 1661130
30 Jun 1660130
31 Mar 1658130
31 Dec 1557230
30 Sep 1556340

Quality Earnings: GENX has high quality earnings.

Growing Profit Margin: GENX's current net profit margins (4%) are lower than last year (5.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: GENX has become profitable over the past 5 years, growing earnings by 45.6% per year.

Accelerating Growth: GENX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: GENX had negative earnings growth (-19.1%) over the past year, making it difficult to compare to the Software industry average (23.5%).


Return on Equity

High ROE: GENX's Return on Equity (9.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/09/13 18:12
End of Day Share Price 2022/08/23 00:00
Earnings2022/03/31
Annual Earnings2022/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Generix SA is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jean Pascal BrivadyCIC Market Solutions (ESN)
Emmanuel MatotODDO BHF Corporate & Markets
Matthias DesmaraisODDO BHF Corporate & Markets